Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal of Oregon.
Press releases published on August 21, 2025
Femasys Announces FemSperm™ Kit to Activate Gynecologists and Advance FemaSeed® Fertility Platform
-- First in the FemSperm family, the Setup Kit enables gynecologists to offer FemaSeed directly, expanding access ahead of IVF and driving revenue growth -- ATLANTA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical …
Parexel Appoints Biotech Business Head Jim Anthony to Expanded Role as Chief Commercial Officer and President, Parexel Biotech
DURHAM, N.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, today announced the appointment of Jim Anthony …
Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™
GAITHERSBURG, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- As opioid emergencies continue to be the leading cause of accidental death in the United States,1 Emergent BioSolutions (NYSE: EBS) is teaming up with Voices for Awareness and Facing Fentanyl Now in …
Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for atumelnant, a novel, once-daily oral adrenocorticotropic …
AMPS to Spotlight ClaimInsight at CAHP 2025, Delivering a Smarter Future for Payment Integrity in California
PHOENIX, Aug. 21, 2025 (GLOBE NEWSWIRE) -- As the California healthcare system faces unprecedented financial strain and legislative complexity, Advanced Medical Pricing Solutions (AMPS) will bring a powerful cost containment solution to center stage at the …
60 Degrees Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference
WASHINGTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne diseases, announced today it will …
Global Single-Cell Sequencing Market to Reach USD 3.46 Billion by 2030 | MarketsandMarkets™
Delray Beach, FL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The global Single Cell Sequencing market, valued at US$1.89 billion in 2024, stood at US$1.95 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a …
ICU Medical to Participate in Upcoming Investor Conferences
SAN CLEMENTE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September: Wells …
Shriners Hospitals for Children Canada golf tournament raises $581,100 for state-of-the-art medical imaging equipment
MONTREAL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The 14th annual Shriners Hospitals for Children Canada Golf Tournament, held on August 7, 2025 at Summerlea Golf and Country Club, united 252 golfers, 47 volunteers, generous sponsors, and community members to …
581 100 $ récoltés pour de l’équipement d’imagerie médicale à la fine pointe lors du Tournoi de golf annuel de l’Hôpital Shriners du Canada
MONTRÉAL, 21 août 2025 (GLOBE NEWSWIRE) -- Le 14e tournoi de golf annuel de l’Hôpital Shriners pour enfants Canada, qui s’est tenu le 7 août 2025 au Summerlea Golf and Country Club, a réuni 252 golfeurs, 47 bénévoles, de généreux commanditaires et des …
Quoin Pharmaceuticals’ NETHERTON NOW Campaign Surpasses One Million Video Views, Amplifying Global Awareness of Netherton Syndrome
ASHBURN, Va., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that its NETHERTON NOW awareness …
Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter
MINNEAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new size of its Dual …
Sienna Announces Completion of $175 Million Offering of 4.112% Series E Senior Unsecured Debentures
NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced today that it has completed its …
Cube Biotech and X-Chem Partner to Enable DNA-encoded Library Screening of NativeMP™-stabilized Membrane Proteins
MONHEIM, Germany and Waltham, Mass. , Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cube Biotech, a pioneer in membrane protein stabilization and purification, and X-Chem, the global leader in DNA-Encoded Library (DEL) technology and data-driven drug discovery, are …
Cue Biopharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference
BOSTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Beacon Therapeutics Announces EURETINA 2025 Presentations on 9+-Month Phase 2 DAWN and 36-Month Phase 2 SKYLINE Trial Data for laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP)
LONDON and CAMBRIDGE, Mass., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a mission to save and restore the vision of patients with …
Valitor Announces Upcoming Presentations at the Ophthalmology Futures Retina Forum and Euretina Conference, Including New Data for its Long-Acting Anti-VEGF Drug Candidate for Wet AMD, VLTR-559
New non-human primate (NHP) data for VLTR-559, a long-acting anti-VEGF therapy that could reduce the dosing frequency for the treatment of wet age-related macular degeneration (AMD) to twice-yearly, will be presented Ophthalmology Futures Retina Forum …
UroGen Pharma to Present at Upcoming Investor Conferences
PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate …
Beta Bionics Announces Participation at Upcoming Investor Conferences
IRVINE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at three upcoming investor conferences (all …
Red Cross 2025 wildfires response is largest domestic operation in recent history
OTTAWA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross today announced that the 2025 wildfires response operation is the largest in the organization’s recent history. Since May, the Red Cross has been providing humanitarian assistance to people …